Housed within the Siteman Cancer Center, the Biologic Therapy Core Facility (BTCF) partners with physicians and scientists to manufacture, characterize, and release complex, clinical-grade cell and gene therapy products, imaging agents, and other biologics to support early-phase clinical trials.
ICTS-supported facility accelerates translation of promising research into improving outcomes for cancer and other related diseases
View Content